October 18, 2017 12:15 AM ET

Healthcare Equipment and Supplies

Company Overview of Baxter Healthcare Corporation

Company Overview

Baxter Healthcare Corporation develops, manufactures, and markets healthcare equipment and instruments. It focuses on critical therapies for life-threatening conditions, specifically with products and services in blood therapies, cardiovascular medicine, medication delivery, and renal therapy. The company offers its products in the United States and internationally. Baxter Healthcare Corporation was formerly known as Travenol Laboratories, Inc. and changed its name to Baxter Healthcare Corporation in July 1987. The company was incorporated in 1966 and is based in Deerfield, Illinois. Baxter Healthcare Corporation operates as a subsidiary of Baxter International Inc.

One Baxter Parkway

Deerfield, IL 60015-4633

United States

Founded in 1966





Key Executives for Baxter Healthcare Corporation

Chief Executive Officer, President, and Chairman
Age: 66
Compensation as of Fiscal Year 2017.

Baxter Healthcare Corporation Key Developments

Baxter Healthcare Corporation Wins $3,284,267,081 Federal Contract

Baxter Healthcare Corp. won a $3,284,267,081 federal contract from the U.S. Department of Veterans Affairs National Acquisition Center for intravenous solutions and administration sets.

Baxter Healthcare Corp. to Pay More Than $18 Million Fine on Sterile Products

Baxter Healthcare Corp. has agreed to pay $18.158 million to resolve its criminal and civil liability arising from Baxter's failure to follow current Good Manufacturing Practices or cGMP when manufacturing sterile drug products in North Carolina, the U.S. Department of Justice announced on January 13, 2017. The resolution includes a deferred prosecution agreement and penalties and forfeiture totaling $16 million and a civil settlement under the False Claims Act (FCA) with the federal government totaling approximately $2.158 million. In a criminal information filed on January 13, 2017, in the Western District of North Carolina, the government charged that, between July 2011 and November 2012, Baxter introduced into interstate commerce drugs that were adulterated under the Federal Food, Drug, and Cosmetic Act (FDCA) because Baxter did not follow cGMP when making those products. At North Cove, Baxter manufactured large-volume sterile intravenous (IV) solutions in a clean room that had high-efficiency particulate absorption (HEPA) filters installed in the ceiling. Air was pushed into the clean room through the HEPA filters. As alleged in the information, during the relevant time period, a Baxter employee reported the presence of mold on the HEPA filters to plant management.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

January 27, 2017
Insightra Medical Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Baxter Healthcare Corporation, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.